Spurstone Advisory Services’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Spurstone Advisory Services's XERS Position: Q3 2026 in Review
Spurstone Advisory Services held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 200 shares worth $1.85K. The position accounts for 0.02% of the portfolio, ranked #62.
Spurstone Advisory Services first reported a position in XERS in Q4 2024 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Spurstone Advisory Services held 200 shares of Xeris Biopharma Holdings worth $1.85K as of Q3 2026.
- Spurstone Advisory Services left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
- Xeris Biopharma Holdings made up 0.02% of Spurstone Advisory Services's portfolio in Q3 2026, its #62 holding.
- Spurstone Advisory Services first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 8 quarters since.
- 246 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Spurstone Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.